MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Immunological principles of levodopa therapy in Parkinson’s disease

    N. Naimov, B. Muminov, S. Jumanazarova, R. Matmurodov, H. Daminova (Tashkent, Uzbekistan)

    Objective: Study of the relationship between serum IL-10 levels in patients with Parkinson's disease and levodopa therapy Background: In Parkinson's disease, dehydroepiandrosterone can lead to…
  • 2026 International Congress

    Levodopa-Induced Dyskinesias in Patients with Parkinson’s Disease in the Uzbek Population

    G. Isroilova, Z. Sayfitdinkhuzhaev (Tashkent, Uzbekistan)

    Objective: To investigate the clinical features and prevalence of levodopa-induced dyskinesias in patients with Parkinson’s disease in the Uzbek population. Background: Levodopa-induced dyskinesias (LID) are…
  • 2026 International Congress

    Impact of Caffeine Consumption on Clinical Phenotype and Non-Motor Symptoms in Parkinson’s Disease

    A. Rekik, M. Abid, R. Guizani, K. Jemai, A. Mili, H. Slimene, A. Hassine, S. Naija, S. Ben Amor (Sousse, Tunisia)

    Objective: To determine the impact of daily caffeine consumption (presence, quantity) on the clinical phenotype of patients with Parkinson’s Disease (PD), focusing on age of…
  • 2026 International Congress

    Latent Classes of Cognitive Decline in Parkinson’s Disease: Neuroimaging and Neurodegenerative Blood Biomarker Correlates

    MC. Mckenna, M. Pasternak, R. Alesker, S. Mirza, S. Black, C. Marras, M. Binns, D. Breen, K. Fishman, D. Grimes, B. Levine, P. Mclaughlin, A. Troyer, R. Bartha, H. Zetterberg, A. Lang, M. Masellis (Toronto, Canada)

    Objective: To identify longitudinal trajectories of cognitive decline in Parkinson’s disease (PD) and to characterize neuroimaging and neurodegenerative blood biomarker correlates. Background: Cognitive impairment affects…
  • 2026 International Congress

    Reduced Slow Wave Sleep is Associated with Mobility Impairment in People with Parkinson’s Disease

    M. Sleyster, A. Miften, A. Amara (Aurora, USA)

    Objective: Determine relationships between functional mobility and slow wave sleep (non-REM stage 3; N3) in Parkinson’s disease (PD). Background: Sleep disturbance is a common non-motor…
  • 2026 International Congress

    The Syn-Sleep Study: Detection of Cutaneous Phosphorylated Alpha-Synuclein in REM Sleep Behavior Disorder

    T. Levine, S. Marcotte, J. Parent, B. Bellaire, M. Duval, R. Freeman, C. Gibbons (scottsdale, USA)

    Objective: The goals of this study are to 1) determine rates of phosphorylated alpha-synuclein (P-SYN) deposition in iRBD, 2) quantify changes in P-SYN deposition over…
  • 2026 International Congress

    Biofluid Markers in Parkinson’s Patients and Correlation with Cognitive Profile

    T. Yamasaki, R. Vivanco, J. Johnson, S. Ali, F. Schmitt, A. Glueck, A. Jacob, S. Hulou, M. Khashimov, K. Tackett, C. Logan, J. Stegemann, E. Song, E. Ostrakhovitch (Lexington, USA)

    Objective: The purpose of this study was to determine potential biofluid biomarkers for cognitive impairment in a cohort of Parkinson's disease (PD) patients. Here we…
  • 2026 International Congress

    Preliminary Genetic Spectrum of Parkinson’s Disease in the Israeli PD GENEration Cohort

    N. Omer, R. Cohen, T. Gurevich, M. Kalish, A. Thaler, V. Linveh, P. Ponger, M. Cohen, G. Yahalom, I. Harari, T. Fay-Karmon, T. Davidi, A. Saar, L. Greenbaum, S. Hassin-Baer, L. Caboy, A. Dilliot, M. Thom, M. Dini, R. Alcalay (Tel Aviv, Israel)

    Objective: To characterize the preliminary genetic spectrum of the Israeli PD GENEration cohort. Background: The PD GENEration study (NCT04994015) provides genetic testing and counseling for…
  • 2026 International Congress

    The Relationship Between Neurobehavioral Profile and Cognitive Phenotype in Patients with Idiopathic Parkinson’s Disease Without Dementia.

    C. Hurtado-González, J. Ayala-Rico, S. Ospina Otalvaro, P. Gutiérrez-Lenis, A. Cubides-Munévar, A. Botero-Carvajal, J. Centeno-Arispe, D. Reyes-Torres, K. Ponce-Gil, J. Cedeño-Buitrago, L. Ortega-Bolaños (Cali, Colombia)

    Objective: To identify the neurobehavioral profile and cognitive phenotype in patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Background: Depression is one of the most…
  • 2026 International Congress

    Impact of Variants in ADH1B and ALDH2 on Parkinson’s Disease in Japan

    M. Kinoshita, H. Ohara, R. Sasaki, K. Tamura, M. Iyer, B. Vellingiri (Kyoto, Japan)

    Objective: We analyzed the relationship among prevalence of Parkinson’s disease, the variants in ADH1B and ALDH2, alcohol consumption and smoking per population among Japanese prefectures.…
  • « Previous Page
  • 1
  • …
  • 108
  • 109
  • 110
  • 111
  • 112
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley